栗山 直英

Medicine & Life Sciences

1. Sepsis 100%
2. Coronavirus 85%
3. Hemofiltration 76%
4. Adsorption 76%
5. Septic Shock 74%
6. Membranes 70%
7. polyacrylonitrile 61%
8. Polymethyl Methacrylate 53%
9. Farnesyltranstransferase 51%
10. Extracellular Traps 47%
11. Hemoperfusion 47%
12. HMGB1 Protein 47%
13. Polymyxin B 44%
14. Thermodilution 44%
15. Extracorporeal Membrane Oxygenation 43%
16. Linezolid 43%
17. Observational Studies 42%
18. Lipopolysaccharides 40%
19. In Vitro Techniques 39%
20. Acute Kidney Injury 38%
21. human THBD protein 34%
22. Interleukin-6 32%
23. Cytokines 30%
24. ubiquinol-10 29%
25. nafamostat 27%
26. Doripenem 27%
27. Polycystic liver disease 27%
28. Tumor Lysis Syndrome 25%
29. Neutrophils 25%
30. Retrospective Studies 25%
31. SARS Virus 25%
32. Lopinavir 24%
33. Mucormycosis 23%
34. Lung 23%
35. Cardiac Output 23%
36. Polyethyleneimine 22%
37. Lipodystrophy 22%
38. Cefepime 22%
39. Lipocalin-2 22%
40. Thrombomodulin 22%
41. Continuous Renal Replacement Therapy 22%
42. coenzyme Q10 22%
43. Pancreatic Diseases 21%
44. Myosin Light Chains 21%
45. polysulfone P 1700 21%
46. Ritonavir 21%
47. Renal Replacement Therapy 21%
48. Myoglobin 21%
49. Hypoxia-Inducible Factor 1 21%
50. Intensive Care Units 21%